Skip to contentEDELMAN JOSEPH — BIOSANTE PHARMACEUTICALS INC insider: 319 transactions · InsiderLensEDELMAN JOSEPH
- 10% owner at SOLENO THERAPEUTICS INC · on record since May 26, 2023
- 10% owner at CHEMBIO DIAGNOSTICS, INC. · on record since Apr 25, 2023
- Former 10% Owner at CHEMBIO DIAGNOSTICS, INC. · on record since May 1, 2023
- Director at LeonaBio, Inc. · on record since Apr 13, 2026
- 10% owner at INDEVUS PHARMACEUTICALS INC · on record since Jun 29, 2006
- Former 10% Owner at CARGO Therapeutics, Inc. · on record since Nov 14, 2023
- 10% owner at CARGO Therapeutics, Inc. · on record since Nov 9, 2023
- 10% owner at FELAFEL CORP · on record since Jun 27, 2024
- Director at Perceptive Capital Solutions Corp · on record since Jun 11, 2024
- 10% owner at Orchestra BioMed Holdings, Inc. · on record since Jul 17, 2024
- 10% owner at Adagio Medical Holdings, Inc. · on record since Aug 1, 2024
- 10% owner at Rain Enhancement Technologies Holdco, Inc. · on record since Apr 27, 2021
- 10% owner at BIOENVISION INC · on record since Aug 22, 2007
- Director at Adagio Medical Holdings, Inc. · on record since Feb 14, 2025
- 10% owner at XTL BIOPHARMACEUTICALS LTD · on record since Dec 31, 2007
- 10% owner at MACROCHEM CORP · on record since Dec 28, 2007
- 10% owner at OPTIMER PHARMACEUTICALS INC · on record since Dec 27, 2007
- 10% owner at PENWEST PHARMACEUTICALS CO · on record since Jan 31, 2008
- Director at Immatics N.V. · on record since Mar 18, 2026
- Director at Kardigan, Inc. · on record since Jun 18, 2026
- 10% owner at CYPRESS BIOSCIENCE INC · on record since Aug 8, 2003
- 10% owner at BIOSANTE PHARMACEUTICALS INC · on record since Aug 13, 2003
- 10% owner at MIRAVANT MEDICAL TECHNOLOGIES · on record since Jun 8, 2004
- 10% owner at TRIMERIS INC · on record since Jul 29, 2011
- 10% owner at ZONAGEN INC · on record since Aug 24, 2011
- Director at MeiraGTx Holdings plc · on record since Apr 23, 2026
- 10% owner at MeiraGTx Holdings plc · on record since Apr 23, 2026
- 10% owner at ACELRX PHARMACEUTICALS INC · on record since Dec 13, 2012
- 10% owner at Aegerion Pharmaceuticals, Inc. · on record since Dec 5, 2012
- 10% owner at ANTARES PHARMA INC · on record since Feb 12, 2004
- 10% owner at AMICUS THERAPEUTICS INC · on record since May 30, 2014
- Director at Solid Biosciences Inc. · on record since Jun 11, 2026
- 10% owner at Solid Biosciences Inc. · on record since Jun 11, 2026
- 10% owner at PAULSON CAPITAL CORP · on record since Mar 11, 2015
- 10% owner at Aldeyra Therapeutics, Inc. · on record since Oct 28, 2015
- Former Director at Nautilus Biotechnology, Inc. · on record since Jun 11, 2021
- 10% owner at Versartis, Inc. · on record since Sep 28, 2016
- No longer a 10% Owner. at AMICUS THERAPEUTICS INC · on record since Aug 26, 2016
- 10% owner at Kadmon Holdings, LLC · on record since Mar 20, 2017
- 10% owner at CORILLIAN CORP · on record since May 25, 2017
- 10% owner at ZOGENIX, INC. · on record since May 18, 2017
- 10% owner at Quotient Ltd · on record since Oct 26, 2017
- 10% owner at Global Blood Therapeutics, Inc. · on record since Dec 19, 2017
- 10% owner at LA JOLLA PHARMACEUTICAL CO · on record since Dec 18, 2017
- 10% owner at R&R ACQUISITION VI, INC · on record since Nov 15, 2017
- 10% owner at Biodel Inc · on record since Dec 4, 2017
- 10% owner at AGILE THERAPEUTICS INC · on record since Mar 28, 2018
- 10% owner at Motus GI Holdings, Inc. · on record since Feb 21, 2018
- 10% owner at Dova Pharmaceuticals, Inc. · on record since Jun 13, 2018
- 10% owner at Crinetics Pharmaceuticals, Inc. · on record since Aug 27, 2018
- Former 10% Owner at AGILE THERAPEUTICS INC · on record since Jul 26, 2018
- Former 10% Owner at Global Blood Therapeutics, Inc. · on record since Jul 25, 2018
- 10% owner at Verrica Pharmaceuticals Inc. · on record since Aug 1, 2018
- Director at ARYA SCIENCES ACQUISITION CORP. · on record since Oct 5, 2018
- 10% owner at Athenex, Inc. · on record since Jun 20, 2019
- 10% owner at Foamix Pharmaceuticals Ltd. · on record since Aug 6, 2019
- Director at Lyra Therapeutics, Inc. · on record since Apr 30, 2020
- 10% owner at Lyra Therapeutics, Inc. · on record since Apr 30, 2020
- 10% owner at LEAP THERAPEUTICS, INC. · on record since Jun 24, 2020
- Director at VYNE Therapeutics Inc. · on record since Jun 11, 2020
- 10% owner at VYNE Therapeutics Inc. · on record since Jun 11, 2020
- Director at ARYA Sciences Acquisition Corp II · on record since Jun 4, 2020
- 10% owner at LeonaBio, Inc. · on record since Sep 22, 2020
- Director at Ceres, Inc. · on record since Oct 29, 2020
- 10% owner at SCYNEXIS INC · on record since Jan 26, 2021
- Director at ARYA Sciences Acquisition Corp IV · on record since Feb 25, 2021
- 10% owner at Ignyta, Inc. · on record since Mar 16, 2021
- Director at Landos Biopharma, Inc. · on record since Feb 9, 2021
- 10% owner at Landos Biopharma, Inc. · on record since Feb 9, 2021
- Director at CATABASIS PHARMACEUTICALS INC · on record since Feb 3, 2021
- 10% owner at CATABASIS PHARMACEUTICALS INC · on record since Feb 3, 2021
- Director at ARYA Sciences Acquisition Corp V · on record since Jul 12, 2021
- 10% owner at LianBio · on record since Oct 29, 2021
- 10% owner at ISCO INTERNATIONAL INC · on record since Oct 14, 2021
- 10% owner at Nautilus Biotechnology, Inc. · on record since Dec 10, 2021
- Director at LianBio · on record since Nov 5, 2021
- Director at Nautilus Biotechnology, Inc. · on record since Jun 17, 2022
- 10% owner at Acrivon Therapeutics, Inc. · on record since Nov 18, 2022
Insider trading activity of EDELMAN JOSEPH
- Transactions on record
- 319
- since Aug 8, 2003
- Open-market buys
- 179
- $302.7M
- Open-market sells
- 85
- $23.9M
- Companies traded
- 40
- last filing Jun 24, 2026
Figures computed from official regulatory filings — methodology.
Companies where EDELMAN JOSEPH has traded
- LeonaBio, Inc.16 tx · $30.6M · Jun 24, 2026
- Lyra Therapeutics, Inc.6 tx · $344.3K · Nov 10, 2025
- Adagio Medical Holdings, Inc.4 tx · $4.2M · Oct 22, 2025
- Solid Biosciences Inc.11 tx · $65.4M · Jun 13, 2025
- MeiraGTx Holdings plc5 tx · $15M · Aug 14, 2024
- Aldeyra Therapeutics, Inc.6 tx · $15.4M · Apr 8, 2024
- Verrica Pharmaceuticals Inc.3 tx · $2.3M · Dec 29, 2023
- CARGO Therapeutics, Inc.4 tx · $10M · Nov 14, 2023
- Ceres, Inc.2 tx · $22.1M · Oct 17, 2023
Track record of EDELMAN JOSEPH
Statistical track record
Free- Open-market buys
- 192
- Last buy
- Oct 20, 2025
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of EDELMAN JOSEPH
Co-insiders of EDELMAN JOSEPH
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
3 tx · $449.8K · May 26, 2023
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 24, 2026 | AwardD | 28,000 | 0.00 USD | — | SEC |
| Apr 13, 2026 | AwardD | 28,000 | 0.00 USD | $0 | SEC |
| Nov 10, 2025 | Sell | -28,902 | 5.18 USD | $149.7K | SEC |
| Nov 10, 2025 | Sell | -1,993 | 4.75 USD | $9.5K | SEC |
| Nov 10, 2025 | Sell | -3,247 | 5.18 USD | $16.8K | SEC |
| Nov 10, 2025 | Sell | -16,633 | 4.54 USD | $75.5K | SEC |
| Nov 10, 2025 | Sell | -17,746 | 4.75 USD | $84.3K | SEC |
| Nov 10, 2025 | Sell | -1,869 | 4.54 USD | $8.5K | SEC |
| Oct 22, 2025 | BuyD | 2,190,496 | 1.60 USD | $3.5M | SEC |
| Oct 22, 2025 | BuyD | 1,344,999 | 0.18 USD | $242.1K | SEC |
| Oct 22, 2025 | BuyD | 1,344,999 | 0.18 USD | $242.1K | SEC |
| Oct 22, 2025 | BuyD | 1,344,999 | 0.18 USD | $242.1K | SEC |
| Jun 13, 2025 | AwardD | 77,500 | 0.00 USD | $0 | SEC |
| Jun 3, 2025 | AwardD | 20,900 | 0.00 USD | $0 | SEC |
| Feb 21, 2025 | Buy | 5,000,000 | 4.03 USD | $20.2M | SEC |
| Nov 19, 2024 | AwardD | 34,400 | 0.00 USD | $0 | SEC |
| Aug 14, 2024 | Buy | 1,250,000 | 4.00 USD | $5M | SEC |
| Jun 7, 2024 | AwardD | 45,000 | 0.00 USD | $0 | SEC |
| May 24, 2024 | AwardD | 20,900 | 0.00 USD | $0 | SEC |
| Apr 8, 2024 | Buy | 37,712 | 4.74 USD | $178.8K | SEC |
| Apr 8, 2024 | Buy | 140,281 | 4.67 USD | $655.1K | SEC |
| Dec 29, 2023 | Buy | 79,726 | 7.20 USD | $574K | SEC |
| Dec 29, 2023 | Buy | 32,134 | 2.28 USD | $73.3K | SEC |
| Dec 29, 2023 | Buy | 163,954 | 2.38 USD | $390.2K | SEC |
| Dec 29, 2023 | Buy | 115,774 | 7.24 USD | $838.2K | SEC |